Pre-order Enquiry
Request Free Sample
Global Daunorubicin Hydrochloride (CAS 23541-50-6) Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID : QYR-16957589 | Publishing Date : 09-Dec-2020 | No. of pages : 115
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Daunorubicin Hydrochloride (CAS 23541-50-6) Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application
1 Daunorubicin Hydrochloride (CAS 23541-50-6) Market Overview1.1 Daunorubicin Hydrochloride (CAS 23541-50-6) Product Overview
1.2 Daunorubicin Hydrochloride (CAS 23541-50-6) Market Segment by Type
1.2.1 5mg/ml
1.2.2 2mg/ml
1.3 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size by Type (2015-2026)
1.3.1 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size Overview by Type (2015-2026)
1.3.2 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Historic Market Size Review by Type (2015-2020)
1.3.2.1 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share Breakdown by Type (2015-2026)
1.3.2.2 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share Breakdown by Type (2015-2026)
1.3.2.3 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Average Selling Price (ASP) by Type (2015-2026)
1.3.3 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size Forecast by Type (2021-2026)
1.3.3.1 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share Breakdown by Application (2021-2026)
1.3.3.2 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share Breakdown by Application (2021-2026)
1.3.3.3 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Average Selling Price (ASP) by Application (2021-2026)
1.4 Key Regions Market Size Segment by Type (2015-2020)
1.4.1 North America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Breakdown by Type (2015-2026)
1.4.2 Europe Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Breakdown by Type (2015-2026)
1.4.3 Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Breakdown by Type (2015-2026)
1.4.4 Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Breakdown by Type (2015-2026)
1.4.5 Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Breakdown by Type (2015-2026)
2 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Market Competition by Company
2.1 Global Top Players by Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (2015-2020)
2.2 Global Top Players by Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (2015-2020)
2.3 Global Top Players Daunorubicin Hydrochloride (CAS 23541-50-6) Average Selling Price (ASP) (2015-2020)
2.4 Global Top Manufacturers Daunorubicin Hydrochloride (CAS 23541-50-6) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Daunorubicin Hydrochloride (CAS 23541-50-6) Market Competitive Situation and Trends
2.5.1 Daunorubicin Hydrochloride (CAS 23541-50-6) Market Concentration Rate (2015-2020)
2.5.2 Global 5 and 10 Largest Manufacturers by Daunorubicin Hydrochloride (CAS 23541-50-6) Sales and Revenue in 2019
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Daunorubicin Hydrochloride (CAS 23541-50-6) as of 2019)
2.7 Date of Key Manufacturers Enter into Daunorubicin Hydrochloride (CAS 23541-50-6) Market
2.8 Key Manufacturers Daunorubicin Hydrochloride (CAS 23541-50-6) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Status and Outlook by Region (2015-2026)
3.1 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size and CAGR by Region: 2015 VS 2020 VS 2026
3.2 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size Market Share by Region (2015-2020)
3.2.1 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Region (2015-2020)
3.2.2 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Region (2015-2020)
3.2.3 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales, Revenue, Price and Gross Margin (2015-2020)
3.3 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size Market Share by Region (2021-2026)
3.3.1 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Region (2021-2026)
3.3.2 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Region (2021-2026)
3.3.3 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales, Revenue, Price and Gross Margin (2021-2026)
3.4 North America Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
3.4.1 North America Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue YoY Growth (2015-2026)
3.4.2 North America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales YoY Growth (2015-2026)
3.5 Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
3.5.1 Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue YoY Growth (2015-2026)
3.5.2 Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) Sales YoY Growth (2015-2026)
3.6 Europe Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
3.6.1 Europe Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue YoY Growth (2015-2026)
3.6.2 Europe Daunorubicin Hydrochloride (CAS 23541-50-6) Sales YoY Growth (2015-2026)
3.7 Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
3.7.1 Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue YoY Growth (2015-2026)
3.7.2 Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales YoY Growth (2015-2026)
3.8 Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
3.8.1 Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue YoY Growth (2015-2026)
3.8.2 Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Sales YoY Growth (2015-2026)
4 Global Daunorubicin Hydrochloride (CAS 23541-50-6) by Application
4.1 Daunorubicin Hydrochloride (CAS 23541-50-6) Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales by Application: 2015 VS 2020 VS 2026
4.3 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Historic Sales by Application (2015-2020)
4.4 Global Daunorubicin Hydrochloride (CAS 23541-50-6) Forecasted Sales by Application (2021-2026)
4.5 Key Regions Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size by Application
4.5.1 North America Daunorubicin Hydrochloride (CAS 23541-50-6) by Application
4.5.2 Europe Daunorubicin Hydrochloride (CAS 23541-50-6) by Application
4.5.3 Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) by Application
4.5.4 Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) by Application
4.5.5 Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) by Application
5 North America Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size by Country (2015-2026)
5.1 North America Market Size Market Share by Country (2015-2020)
5.1.1 North America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Country (2015-2020)
5.1.2 North America Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Country (2015-2020)
5.2 North America Market Size Market Share by Country (2021-2026)
5.2.1 North America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Country (2021-2026)
5.2.2 North America Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Country (2021-2026)
5.3 North America Market Size YoY Growth by Country
5.3.1 U.S. Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
5.3.2 Canada Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
6 Europe Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size by Country (2015-2026)
6.1 Europe Market Size Market Share by Country (2015-2020)
6.1.1 Europe Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Country (2015-2020)
6.1.2 Europe Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Country (2015-2020)
6.2 Europe Market Size Market Share by Country (2021-2026)
6.2.1 Europe Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Country (2021-2026)
6.2.2 Europe Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Country (2021-2026)
6.3 Europe Market Size YoY Growth by Country
6.3.1 Germany Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
6.3.2 France Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
6.3.3 U.K. Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
6.3.4 Italy Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
6.3.5 Russia Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
7 Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size by Country (2015-2026)
7.1 Asia-Pacific Market Size Market Share by Country (2015-2020)
7.1.1 Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Country (2015-2020)
7.1.2 Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Country (2015-2020)
7.2 Asia-Pacific Market Size Market Share by Country (2021-2026)
7.2.1 Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Country (2021-2026)
7.2.2 Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Country (2021-2026)
7.3 Asia-Pacific Market Size YoY Growth by Country
7.3.1 China Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
7.3.2 Japan Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
7.3.3 South Korea Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
7.3.4 India Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
7.3.5 Australia Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
7.3.6 Taiwan Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
7.3.7 Indonesia Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
7.3.8 Thailand Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
7.3.9 Malaysia Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
7.3.10 Philippines Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
7.3.11 Vietnam Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
8 Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size by Country (2015-2026)
8.1 Latin America Market Size Market Share by Country (2015-2020)
8.1.1 Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Country (2015-2020)
8.1.2 Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Country (2015-2020)
8.2 Latin America Market Size Market Share by Country (2021-2026)
8.2.1 Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Country (2021-2026)
8.2.2 Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Country (2021-2026)
8.3 Latin America Market Size YoY Growth by Country
8.3.1 Mexico Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
8.3.2 Brazil Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
8.3.3 Argentina Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
9 Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size by Country (2015-2026)
9.1 Middle East and Africa Market Size Market Share by Country (2015-2020)
9.1.1 Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Country (2015-2020)
9.1.2 Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Country (2015-2020)
9.2 Middle East and Africa Market Size Market Share by Country (2021-2026)
9.2.1 Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Country (2021-2026)
9.2.2 Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Country (2021-2026)
9.3 Middle East and Africa Market Size YoY Growth by Country
9.3.1 Turkey Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
9.3.2 Saudi Arabia Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
9.3.3 U.A.E Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size YoY Growth (2015-2026)
10 Company Profiles and Key Figures in Daunorubicin Hydrochloride (CAS 23541-50-6) Business
10.1 Hisun Pharma
10.1.1 Hisun Pharma Corporation Information
10.1.2 Hisun Pharma Description, Business Overview and Total Revenue
10.1.3 Hisun Pharma Daunorubicin Hydrochloride (CAS 23541-50-6) Sales, Revenue and Gross Margin (2015-2020)
10.1.4 Hisun Pharma Daunorubicin Hydrochloride (CAS 23541-50-6) Products Offered
10.1.5 Hisun Pharma Recent Development
10.2 Main Luck Pharma
10.2.1 Main Luck Pharma Corporation Information
10.2.2 Main Luck Pharma Description, Business Overview and Total Revenue
10.2.3 Main Luck Pharma Daunorubicin Hydrochloride (CAS 23541-50-6) Sales, Revenue and Gross Margin (2015-2020)
10.2.4 Hisun Pharma Daunorubicin Hydrochloride (CAS 23541-50-6) Products Offered
10.2.5 Main Luck Pharma Recent Development
10.3 Pfizer
10.3.1 Pfizer Corporation Information
10.3.2 Pfizer Description, Business Overview and Total Revenue
10.3.3 Pfizer Daunorubicin Hydrochloride (CAS 23541-50-6) Sales, Revenue and Gross Margin (2015-2020)
10.3.4 Pfizer Daunorubicin Hydrochloride (CAS 23541-50-6) Products Offered
10.3.5 Pfizer Recent Development
10.4 Cipla
10.4.1 Cipla Corporation Information
10.4.2 Cipla Description, Business Overview and Total Revenue
10.4.3 Cipla Daunorubicin Hydrochloride (CAS 23541-50-6) Sales, Revenue and Gross Margin (2015-2020)
10.4.4 Cipla Daunorubicin Hydrochloride (CAS 23541-50-6) Products Offered
10.4.5 Cipla Recent Development
10.5 TEVA
10.5.1 TEVA Corporation Information
10.5.2 TEVA Description, Business Overview and Total Revenue
10.5.3 TEVA Daunorubicin Hydrochloride (CAS 23541-50-6) Sales, Revenue and Gross Margin (2015-2020)
10.5.4 TEVA Daunorubicin Hydrochloride (CAS 23541-50-6) Products Offered
10.5.5 TEVA Recent Development
10.6 Medior Healthcare
10.6.1 Medior Healthcare Corporation Information
10.6.2 Medior Healthcare Description, Business Overview and Total Revenue
10.6.3 Medior Healthcare Daunorubicin Hydrochloride (CAS 23541-50-6) Sales, Revenue and Gross Margin (2015-2020)
10.6.4 Medior Healthcare Daunorubicin Hydrochloride (CAS 23541-50-6) Products Offered
10.6.5 Medior Healthcare Recent Development
10.7 United Biotech
10.7.1 United Biotech Corporation Information
10.7.2 United Biotech Description, Business Overview and Total Revenue
10.7.3 United Biotech Daunorubicin Hydrochloride (CAS 23541-50-6) Sales, Revenue and Gross Margin (2015-2020)
10.7.4 United Biotech Daunorubicin Hydrochloride (CAS 23541-50-6) Products Offered
10.7.5 United Biotech Recent Development
10.8 West-Ward
10.8.1 West-Ward Corporation Information
10.8.2 West-Ward Description, Business Overview and Total Revenue
10.8.3 West-Ward Daunorubicin Hydrochloride (CAS 23541-50-6) Sales, Revenue and Gross Margin (2015-2020)
10.8.4 West-Ward Daunorubicin Hydrochloride (CAS 23541-50-6) Products Offered
10.8.5 West-Ward Recent Development
11 Daunorubicin Hydrochloride (CAS 23541-50-6) Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Daunorubicin Hydrochloride (CAS 23541-50-6) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Daunorubicin Hydrochloride (CAS 23541-50-6) Industrial Chain Analysis
11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Porter’s Five Forces Analysis
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Distributors
12.3 Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Author Details
14.4 Disclaimer
List of Figures, Tables and Charts Available in Global Daunorubicin Hydrochloride (CAS 23541-50-6) Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application
List of TablesTable 1. Major Company of 5mg/ml
Table 2. Major Company of 2mg/ml
Table 3. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size Growth Potential by Type: CAGR (2020-2026) (US$ Million)
Table 4. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Type (2015-2020) (Kg)
Table 5. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Share by Type (2015-2020)
Table 6. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (Million USD) by Type (2015-2020)
Table 7. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Share by Type (2015-2020)
Table 8. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Average Selling Price (ASP) (USD/Kg) by Type (2015-2020)
Table 9. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales by Type (2021-2026) (Kg)
Table 10. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Share by Type (2021-2026)
Table 11. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) by Type (2021-2026)
Table 12. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Share by Type (2021-2026)
Table 13. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Average Selling Price (ASP) (USD/Kg) by Type (2021-2026)
Table 14. North America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (USD/Kg) by Type (2015-2020)
Table 15. Europe Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (USD/Kg) by Type (2015-2020)
Table 16. Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (USD/Kg) by Type (2015-2020)
Table 17. Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (USD/Kg) by Type (2015-2020)
Table 18. Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (USD/Kg) by Type (2015-2020)
Table 19. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Company (2015-2020)
Table 20. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Share by Company (2015-2020)
Table 21. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (Million US$) by Company (2015-2020)
Table 22. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Share by Company (2015-2020)
Table 23. Global Market Daunorubicin Hydrochloride (CAS 23541-50-6) Average Selling Price (USD/Kg) by Company (2015-2020)
Table 24. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 25. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Top Manufacturers Product Category
Table 26. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Daunorubicin Hydrochloride (CAS 23541-50-6) as of 2019
Table 28. Date of Key Manufacturers Enter into Daunorubicin Hydrochloride (CAS 23541-50-6) Market
Table 29. Key Manufacturers Daunorubicin Hydrochloride (CAS 23541-50-6) Product Type
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Market Size Comparison by Region (2015-2026) (US$ Million): 2015 VS 2020 VS 2026
Table 32. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Region (2015-2020)
Table 33. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Region (2015-2020)
Table 34. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) by Region (2015-2020)
Table 35. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Region (2015-2020)
Table 36. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 37. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Region (2021-2026)
Table 38. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Region (2021-2026)
Table 39. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) by Region (2021-2026)
Table 40. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Region (2021-2026)
Table 41. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 42. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Application: 2015 VS 2020 VS 2026
Table 43. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Application (2015-2020)
Table 44. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Share by Application (2015-2020)
Table 45. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Application (2021-2026)
Table 46. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Share by Application (2021-2026)
Table 47. North America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Application (2015-2020)
Table 48. North America Sales Daunorubicin Hydrochloride (CAS 23541-50-6) Market Share by Application (2015-2020)
Table 49. Europe Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Application (2015-2020)
Table 50. Europe Sales Daunorubicin Hydrochloride (CAS 23541-50-6) Market Share by Application In 2019
Table 51. Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Application (2015-2020)
Table 52. Asia-Pacific Sales Daunorubicin Hydrochloride (CAS 23541-50-6) Market Share by Application In 2019
Table 53. Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Application (2015-2020)
Table 54. Latin America Sales Daunorubicin Hydrochloride (CAS 23541-50-6) Market Share by Application In 2019
Table 55. Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Application (2015-2020)
Table 56. Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Share by Application (2015-2020)
Table 57. North America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Country (2015-2020)
Table 58. North America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Country (2015-2020)
Table 59. North America Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) by Country (2015-2020)
Table 60. North America Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Country (2015-2020)
Table 61. North America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Country (2021-2026)
Table 62. North America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Country (2021-2026)
Table 63. North America Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) by Country (2021-2026)
Table 64. North America Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Country (2021-2026)
Table 65. Europe Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Country (2015-2020)
Table 66. Europe Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Country (2015-2020)
Table 67. Europe Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) by Country (2015-2020)
Table 68. Europe Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Country (2015-2020)
Table 69. Europe Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Country (2021-2026)
Table 70. Europe Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Country (2021-2026)
Table 71. Europe Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) by Country (2021-2026)
Table 72. Europe Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Country (2021-2026)
Table 73. Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Region (2015-2020)
Table 74. Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Region (2015-2020)
Table 75. Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) by Region (2015-2020)
Table 76. Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Region (2015-2020)
Table 77. Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Region (2021-2026)
Table 78. Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Region (2021-2026)
Table 79. Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) by Region (2021-2026)
Table 80. Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Region (2021-2026)
Table 81. Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Country (2015-2020)
Table 82. Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Country (2015-2020)
Table 83. Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) by Country (2015-2020)
Table 84. Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Country (2015-2020)
Table 85. Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Country (2021-2026)
Table 86. Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Country (2021-2026)
Table 87. Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) by Country (2021-2026)
Table 88. Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Country (2021-2026)
Table 89. Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Country (2015-2020)
Table 90. Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Country (2015-2020)
Table 91. Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) by Country (2015-2020)
Table 92. Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Country (2015-2020)
Table 93. Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) by Country (2021-2026)
Table 94. Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Country (2021-2026)
Table 95. Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) by Country (2021-2026)
Table 96. Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Country (2021-2026)
Table 97. Hisun Pharma Corporation Information
Table 98. Hisun Pharma Description and Business Overview
Table 99. Hisun Pharma Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 100. Hisun Pharma Daunorubicin Hydrochloride (CAS 23541-50-6) Product
Table 101. Hisun Pharma Recent Development
Table 102. Main Luck Pharma Corporation Information
Table 103. Main Luck Pharma Description and Business Overview
Table 104. Main Luck Pharma Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 105. Main Luck Pharma Daunorubicin Hydrochloride (CAS 23541-50-6) Product
Table 106. Main Luck Pharma Recent Development
Table 107. Pfizer Corporation Information
Table 108. Pfizer Description and Business Overview
Table 109. Pfizer Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 110. Pfizer Daunorubicin Hydrochloride (CAS 23541-50-6) Product
Table 111. Pfizer Recent Development
Table 112. Cipla Corporation Information
Table 113. Cipla Description and Business Overview
Table 114. Cipla Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 115. Cipla Daunorubicin Hydrochloride (CAS 23541-50-6) Product
Table 116. Cipla Recent Development
Table 117. TEVA Corporation Information
Table 118. TEVA Description and Business Overview
Table 119. TEVA Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 120. TEVA Daunorubicin Hydrochloride (CAS 23541-50-6) Product
Table 121. TEVA Recent Development
Table 122. Medior Healthcare Corporation Information
Table 123. Medior Healthcare Description and Business Overview
Table 124. Medior Healthcare Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 125. Medior Healthcare Daunorubicin Hydrochloride (CAS 23541-50-6) Product
Table 126. Medior Healthcare Recent Development
Table 127. United Biotech Corporation Information
Table 128. United Biotech Description and Business Overview
Table 129. United Biotech Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 130. United Biotech Daunorubicin Hydrochloride (CAS 23541-50-6) Product
Table 131. United Biotech Recent Development
Table 132. West-Ward Corporation Information
Table 133. West-Ward Description and Business Overview
Table 134. West-Ward Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 135. West-Ward Daunorubicin Hydrochloride (CAS 23541-50-6) Product
Table 136. West-Ward Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 140. Key Challenges
Table 141. Market Risks
Table 142. Distributors List
Table 143. Daunorubicin Hydrochloride (CAS 23541-50-6) Downstream Customers
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Daunorubicin Hydrochloride (CAS 23541-50-6) Product Picture
Figure 2. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (Million USD) Status and Outlook (2015-2026)
Figure 3. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) Status and Outlook (2015-2026)
Figure 4. Product Picture of 5mg/ml
Figure 5. Global 5mg/ml Sales (Kg) and Growth Rate (2015-2020)
Figure 6. Product Picture of 2mg/ml
Figure 7. Global 2mg/ml Sales (Kg) and Growth Rate (2015-2020)
Figure 8. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue and Growth Rate by Type (US$ Million)
Figure 9. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Type (2015-2020)
Figure 10. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Type in 2019
Figure 11. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Share by Type (2015-2020)
Figure 12. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Type in 2019
Figure 13. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Type (2021-2026)
Figure 14. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Sales Market Share by Type In 2019
Figure 15. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Share by Type (2021-2026)
Figure 16. Global Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue Market Share by Type In 2019
Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by Daunorubicin Hydrochloride (CAS 23541-50-6) Sales in 2019
Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue in 2019
Figure 19. Daunorubicin Hydrochloride (CAS 23541-50-6) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. North America Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) and Growth Rate (2015-2026)
Figure 21. North America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales YoY Growth (2015-2026) (Kg)
Figure 22. Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) and Growth Rate (2015-2026)
Figure 23. Asia-Pacific Daunorubicin Hydrochloride (CAS 23541-50-6) Sales YoY Growth (2015-2026) (Kg)
Figure 24. Europe Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) and Growth Rate (2015-2026)
Figure 25. Europe Daunorubicin Hydrochloride (CAS 23541-50-6) Sales YoY Growth (2015-2026) (Kg)
Figure 26. Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) and Growth Rate (2015-2026)
Figure 27. Latin America Daunorubicin Hydrochloride (CAS 23541-50-6) Sales YoY Growth (2015-2026) (Kg)
Figure 28. Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) and Growth Rate (2015-2026)
Figure 29. Middle East and Africa Daunorubicin Hydrochloride (CAS 23541-50-6) Sales YoY Growth (2015-2026) (Kg)
Figure 30. Hospital Pharmacies Examples
Figure 31. Retail Pharmacies Examples
Figure 32. Online Pharmacies Examples
Figure 33. U.S. Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 34. U.S. Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 35. Canada Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 36. Canada Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 37. Germany Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 38. Germany Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 39. France Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 40. France Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 41. U.K. Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 42. U.K. Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 43. Italy Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 44. Italy Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 45. Russia Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 46. Russia Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 47. China Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 48. China Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 49. Japan Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 50. Japan Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 51. South Korea Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 52. South Korea Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 53. India Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 54. India Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 55. Australia Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 56. Australia Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 57. Taiwan Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 58. Taiwan Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 59. Indonesia Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 60. Indonesia Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 61. Thailand Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 62. Thailand Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 63. Malaysia Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 64. Malaysia Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 65. Philippines Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 66. Philippines Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 67. Vietnam Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 68. Vietnam Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 69. Mexico Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 70. Mexico Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 71. Brazil Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 72. Brazil Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 73. Argentina Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 74. Argentina Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 75. Turkey Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 76. Turkey Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 77. Saudi Arabia Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 78. Saudi Arabia Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 79. U.A.E Daunorubicin Hydrochloride (CAS 23541-50-6) Sales (Kg) (2015-2026)
Figure 80. U.A.E Daunorubicin Hydrochloride (CAS 23541-50-6) Revenue (US$ Million) (2015-2026)
Figure 81. Hisun Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Main Luck Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. TEVA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Medior Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. United Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. West-Ward Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Key Raw Materials Price
Figure 90. Daunorubicin Hydrochloride (CAS 23541-50-6) Manufacturing Cost Structure
Figure 91. Daunorubicin Hydrochloride (CAS 23541-50-6) Industrial Chain Analysis
Figure 92. Porter's Five Forces Analysis
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
Keyplayers in Global Daunorubicin Hydrochloride (CAS 23541-50-6) Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application
Hisun PharmaMain Luck Pharma
Pfizer
Cipla
TEVA
Medior Healthcare
United Biotech
West-Ward
